Practical takeaway: Physical rejuvenation in mice is encouraging but must be interpreted cautiously
BREAKING NEWS APRIL 15, 2026 - In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500
The treatment leads to increased GH and insulin-like growth factor-1 (IGF-1) levels, supporting enhanced lipolysis, metabolic function, and body composition
Rob Berberian at our Newport Beach office
Rotate injection sites to prevent tissue damage and maintain optimal absorption
The b12 intravenous dose and b12 iv dose must be set by doctors